[{"orgOrder":0,"company":"Morinaga Milk Industry Co., LTD","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Bifidobacterium Breve","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Morinaga Milk Industry Co., LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Morinaga Milk Industry Co., LTD \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"Morinaga Milk Industry Co., LTD \/ KGK Science"},{"orgOrder":0,"company":"The Center for Applied Health Sciences, LLC","sponsor":"Biohm Health, LLC","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Bifidobacterium Breve","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"The Center for Applied Health Sciences, LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"The Center for Applied Health Sciences, LLC \/ Biohm Health, LLC","highestDevelopmentStatusID":"1","companyTruncated":"The Center for Applied Health Sciences, LLC \/ Biohm Health, LLC"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"","productType":"Microorganism","year":"2025","type":"Inapplicable","leadProduct":"Bifidobacterium Breve","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Shih Chien Huang","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"","productType":"Microorganism","year":"2025","type":"Inapplicable","leadProduct":"Bifidobacterium Breve","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Shih Chien Huang","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Shih Chien Huang"}]

Find Clinical Drug Pipeline Developments & Deals for Bifidobacterium Breve

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          TCI Co., Ltd.

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          TCI Co., Ltd.

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Details : Bifidobacterium Breve is a Microorganism drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                          Product Name : Undisclosed

                          Product Type : Microorganism

                          Upfront Cash : Inapplicable

                          August 01, 2025

                          Lead Product(s) : Bifidobacterium Breve

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          TCI Co., Ltd.

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          TCI Co., Ltd.

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Details : Bifidobacterium Breve is a Microorganism drug candidate, which is currently being evaluated in clinical studies for the treatment of Overweight.

                          Product Name : Undisclosed

                          Product Type : Microorganism

                          Upfront Cash : Inapplicable

                          July 24, 2025

                          Lead Product(s) : Bifidobacterium Breve

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : Shih Chien Huang

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          The Center for Applied Health Sciences, LLC

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          The Center for Applied Health Sciences, LLC

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          November 14, 2022

                          Lead Product(s) : Bifidobacterium Breve

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Biohm Health, LLC

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Morinaga Milk Industry Co., LTD

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Morinaga Milk Industry Co., LTD

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          December 21, 2020

                          Lead Product(s) : Bifidobacterium Breve

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : KGK Science

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Mónica Olivares Martín; PhD

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Mónica Olivares Martín; PhD

                          Country arrow
                          World Drug Safety EU
                          Not Confirmed

                          Lead Product(s) : Bifidobacterium Breve

                          Therapeutic Area : Pediatrics

                          Study Phase : Phase II

                          Sponsor : European Regional Development Fund | Ministry of Science and Innovation, Spain

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          March 16, 2018

                          Lead Product(s) : Bifidobacterium Breve

                          Therapeutic Area : Pediatrics

                          Highest Development Status : Phase II

                          Sponsor : European Regional Development Fund | Ministry of Science and Innovation, Spain

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank